H.C Wainwright Asserts Buy Stance as ImmunityBio, Inc. (IBRX) Achieves Positive Results on Bladder Cancer Treatment

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.
PharmiWeb

Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...

Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Managed Healthcare Executive

Detalimogene gene therapy shows promising results in bladder cancer trial

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...

Abu Dhabi chef gets new life after 20 years of bladder cancer pain

Discover how Abu Dhabi's Sheikh Shakhbout Medical City transformed the life of chef Mandhish Gomez, who endured over 20 years ...
UroToday

Oncologic Impact of Preoperative Hypoalbuminemia in Elderly Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer

Madrid, Spain (UroToday.com) In this study, the authors attempted to evaluate the impact of hypoalbuminemia on the survival rates of patients older than 80, who were referred for radical cystectomy ...